DNA Methylation
"DNA Methylation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Addition of methyl groups to DNA. DNA methyltransferases (DNA methylases) perform this reaction using S-ADENOSYLMETHIONINE as the methyl group donor.
| Descriptor ID |
D019175
|
| MeSH Number(s) |
G02.111.035.538.161 G02.111.218 G03.059.538.161 G05.206
|
| Concept/Terms |
DNA Methylation- DNA Methylation
- DNA Methylations
- Methylation, DNA
- Methylations, DNA
|
Below are MeSH descriptors whose meaning is more general than "DNA Methylation".
Below are MeSH descriptors whose meaning is more specific than "DNA Methylation".
This graph shows the total number of publications written about "DNA Methylation" by people in this website by year, and whether "DNA Methylation" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 2 | 2 | | 1998 | 0 | 2 | 2 | | 1999 | 1 | 2 | 3 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 0 | 1 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 1 | 3 | | 2006 | 2 | 4 | 6 | | 2007 | 1 | 3 | 4 | | 2008 | 5 | 8 | 13 | | 2009 | 2 | 6 | 8 | | 2010 | 4 | 5 | 9 | | 2011 | 4 | 10 | 14 | | 2012 | 9 | 7 | 16 | | 2013 | 9 | 4 | 13 | | 2014 | 5 | 12 | 17 | | 2015 | 15 | 9 | 24 | | 2016 | 10 | 13 | 23 | | 2017 | 15 | 13 | 28 | | 2018 | 17 | 9 | 26 | | 2019 | 20 | 13 | 33 | | 2020 | 17 | 14 | 31 | | 2021 | 19 | 16 | 35 | | 2022 | 6 | 23 | 29 | | 2023 | 12 | 12 | 24 | | 2024 | 22 | 10 | 32 | | 2025 | 16 | 12 | 28 | | 2026 | 13 | 18 | 31 |
To return to the timeline, click here.
Below are the most recent publications written about "DNA Methylation" by people in Profiles.
-
Kim A, Bhardwaj P, Rehman S, Zhao SJ, Lucas KN, Noronha KJ, Bhatt D, Friedman S, Morotti R, Sundaram RK, Dela Cruz FS, Feinberg TY, Ramakrishnan S, Xue W, Barkauskas DA, Hall D, Shern JF, Sun W, Barr FG, Yi JS, Spurrier J, Yu A, Brenner C, Heer CD, Heske CM, Vasquez JC. NAPRT Expression and Epigenetic Regulation in Pediatric Rhabdomyosarcoma as a Potential Biomarker for NAMPT Inhibition. Mol Cancer Ther. 2026 Oct 02; 25(10):1771-1784.
-
Zhang S, Singh O, Dazelle K, Quezado M, Cimino PJ, Abdullaev Z, Wu J, Lucas CH, Schreck KC, Holdhoff M, Pytel P, Goodwill V, Macaulay R, McDonald W, Seidman R, Wood M, Bharani K, Neltner J, Richard H, Chang K, Szymanski L, Yip S, Mukherjee A, Lopes Abath Neto O, Sharma SJ, Green R, Brown D, Gubbiotti MA, Ballester LY, Eschbacher J, Smith-Cohn M, Gokden M, Vincentelli C, Yong W, Lee J, Mount C, Fulmer J, Sun M, Ligon K, Santi M, Pai EL, Yeaney G, Alexandrescu S, Raghavan R, Fernandes I, Reis GF, Mandel J, Caccamo D, Rao S, Butt OH, Dahiya S, Stone S, Conway K, Nasrallah MP, Fuller C, Toland A, Lukas RV, Cachia D, Uhlmann EJ, McCord M, Helgager J, Han K, Perry A, Perez S, Daoud E, BeDell D, Highfield H, Kobalka P, Nix JS, Nduom E, Neill S, Gilbert MR, Lakis N, Fonseca A, Shen C, Yoda R, Monterroza L, Cohen AL, Cathcart S, Al Amin M, Campian J, Aldape K. High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. Neuro Oncol. 2026 Oct 01; 28(10):2435-2448.
-
Peter JA, Weiser TA, Niswander LA, Batey RT, Wuttke DS. MeCP2 MBD-ID module: a unified DNA/RNA binding interface disrupted in Rett syndrome. Nucleic Acids Res. 2026 Sep 22; 54(18).
-
Parks S, Miller R, Millar L, Barnett B, Jenkins T, Brogaard K, Turek PJ. A multielement male nutritional supplement (AlphaSperm®) induces novel epigenetic changes in sperm DNA. Syst Biol Reprod Med. 2026 Dec; 72(1):299-314.
-
Rolles B, Bewersdorf JP, Kewan T, Blaha O, Stempel JM, Lanino L, Al Ali NH, DeZern AE, Sekeres MA, Uy GL, Urrutia S, Carraway HE, Desai P, Griffiths EA, Stein EM, Brunner AM, McMahon C, Shallis RM, Zeidner JF, Savona MR, Barua S, Chandhok NS, Logothetis C, Bidikian A, Getz TM, Roboz GJ, Wang ES, Harris AC, Amaya ML, Hawkins H, Ball S, Grenet J, Abedi P, Shimony S, Lindsley RC, Xie Z, Madanat YF, Abaza Y, Badar T, Haferlach T, Maciejewski JP, Sallman D, Enjeti A, Al-Rabi K, Halahleh K, Hiwase D, Diez-Campelo M, Valcarcel D, Haferlach C, Pleyer L, Kotsianidis I, Pappa V, Santini V, Consagra A, Al-Kali A, Ogawa S, Nannya Y, Porta MGD, Komrokji RS, Zeidan AM, Stahl M. Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS). Am J Hematol. 2026 Nov; 101(11):2786-2798.
-
Mueller SA, Srinivasan U, Laubach ZM, Schield DR, von Rönn JAC, Safran RJ, Wolf JBW. Covariation of genetic and epigenetic divergence in barn swallows. Genome Res. 2026 Aug 03; 36(8):1561-1573.
-
Garcia JS, Desai P, Zeidner JF, Wolach O, LeBlanc TW, Abedin S, Vachhani P, Sweet K, Moshe Y, Pollyea DA, Lai C, Levitz D, Nachmias B, Mozessohn L, Xavier M, Zuckerman T, Konopleva M, Chen EC, Stahl M, Xu Y, Bui CN, Miu K, Schmidt X, Grunspan M, Lin CW, Ma E, Montez M, Guérin A, Burne R, Easson K, Levesque-Leroux M, Baraka E, Goldberg AD. Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study. Leuk Lymphoma. 2026 Sep; 67(11):2282-2294.
-
LaFlamme CW, Clarkson C, Ibañez K, Wang JY, Sengupta S, Lord J, Valentine V, Bonkowski ES, Almanza Fuerte EP, Olszewski AR, Ghosh S, Jadhav B, Mack T, Lin J, Gibson SB, van Hagen JM, Alders M, Martin-Geary A, Gu B, Kharbanda M, Banka S, Stuart HM, Webster AR, Hosokawa A, Dashnow H, Bajpai R, Pruett-Miller SM, Chaisson MJP, Miller DE, Whiffin N, Eichler EE, Sisodiya SM, Houlden H, Sharp AJ, Sadikovic B, Valentine M, Sadleir LG, Tucci A, Mefford HC. Multiomic approaches identify a rare CCG repeat expansion in BCLAF3 in neurodevelopmental disorders. Genome Med. 2026 Jul 22; 18(1).
-
Borden LE, Cosgrove CM, Washington CR, Thomas SM, Haight PJ, Brown A, Powell K, Harsono A, Mullen M, Crafton S, Jackson AL, Corr BR, Wright JD, Konecny GE, Bae-Jump VL, Podwika SE, Smitherman C, Maxwell GL, Backes FJ, Pothuri B, Ko EM, Arend RC, Thaker PH, Duska LR, Secord AA, Moore KN. MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study. Gynecol Oncol. 2026 Aug; 211:231-237.
-
Alves J, Crestani C, Marroquin SM, Johnston ABE, Ring N, Bowen C, Reglinski M, Doran KS, Zadoks RN, Lynskey NN. Acquisition of a novel restriction modification system regulates genetic flux and gene expression in the hypervirulent and globally disseminated CC17 lineage of group B Streptococcus. Nucleic Acids Res. 2026 Jul 03; 54(13).
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|